Meloxicam in Mohs Micrographic Surgery
Recruiting
Phase 4
Interventional Study
Postoperative Pain, Acute
Skin Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 110
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 300 (estimated)
- Sponsor
- University of Oklahoma · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to explore alternative methods of postoperative pain control in Mohs micrographic surgery. The main aims are:
* To provide more information to the Mohs surgery community regarding postoperative pain control.
* Reducing pain improves the overall comfort and well-being of patients, leading to a better post-operative experience.
* To provide patients with an altern…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All adult patients who consents to the study and are undergoing Mohs micrographic surgery at the University of Oklahoma.
Exclusion Criteria:
* Women who are pregnant, suspected to be pregnant, or planning to become pregnant during the study period will be excluded from parti…
Contacts